These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18362486)

  • 1. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study.
    Mattos RM; Marmo Lucon A; Srougi M
    Urol Int; 2008; 80(2):162-5. PubMed ID: 18362486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
    Waldinger MD; Hengeveld MW; Zwinderman AH; Olivier B
    J Clin Psychopharmacol; 1998 Aug; 18(4):274-81. PubMed ID: 9690692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a tadalafil 5-mg single daily dose on lifelong premature ejaculation: A single-blinded placebo-controlled study.
    Abou Faddan AH; Gaber HD; Oamonov D
    Arab J Urol; 2022; 20(2):100-104. PubMed ID: 35530567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation.
    Aversa A; Pili M; Francomano D; Bruzziches R; Spera E; La Pera G; Spera G
    Int J Impot Res; 2009; 21(4):221-7. PubMed ID: 19474796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
    McMahon C; Althof S; Rosen R; Giuliano F; Miner M; Osterloh IH; Muirhead GJ; Harty B;
    J Sex Med; 2019 Aug; 16(8):1178-1187. PubMed ID: 31351659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analyses of two phase 3 dapoxetine trials.
    Porst H; McMahon CG; Althof SE; Sharlip I; Bull S; Aquilina JW; Tesfaye F; Rivas DA
    J Sex Med; 2010 Jun; 7(6):2231-2242. PubMed ID: 20412423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
    J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine.
    Shabsigh R; Patrick DL; Rowland DL; Bull SA; Tesfaye F; Rothman M
    BJU Int; 2008 Sep; 102(7):824-8. PubMed ID: 18647300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).
    Althof S; Osterloh IH; Muirhead GJ; George K; Girard N;
    J Sex Med; 2019 Aug; 16(8):1188-1198. PubMed ID: 31351660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine.
    McMahon C; Kim SW; Park NC; Chang CP; Rivas D; Tesfaye F; Rothman M; Aquilina J;
    J Sex Med; 2010 Jan; 7(1 Pt 1):256-68. PubMed ID: 19878447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved ejaculatory latency, control and sexual satisfaction when PSD502 is applied topically in men with premature ejaculation: results of a phase III, double-blind, placebo-controlled study.
    Carson C; Wyllie M
    J Sex Med; 2010 Sep; 7(9):3179-89. PubMed ID: 20584124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance With Fluoxetine Use in Men With Primary Premature Ejaculation.
    Jenkins LC; Gonzalez J; Tal R; Guhring P; Parker M; Mulhall JP
    J Sex Med; 2019 Dec; 16(12):1895-1899. PubMed ID: 31735615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study.
    Lee WK; Lee SH; Cho ST; Lee YS; Oh CY; Yoo C; Cho JS; Lee SK; Yang DY
    J Sex Med; 2013 Nov; 10(11):2832-41. PubMed ID: 23937271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: a randomized, double-blind, placebo-controlled, fixed-dose study.
    Shinghal R; Barnes A; Mahar KM; Stier B; Giancaterino L; Condreay LD; Black L; McCallum SW
    J Sex Med; 2013 Oct; 10(10):2506-17. PubMed ID: 23937679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
    Gökçe A; Halis F; Demirtas A; Ekmekcioglu O
    BJU Int; 2011 Apr; 107(8):1274-7. PubMed ID: 21929518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.
    Kim SC; Seo KK
    J Urol; 1998 Feb; 159(2):425-7. PubMed ID: 9649255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions to treat premature ejaculation: a systematic review short report.
    Cooper K; Martyn-St James M; Kaltenthaler E; Dickinson K; Cantrell A
    Health Technol Assess; 2015 Mar; 19(21):1-180, v-vi. PubMed ID: 25768099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of serum nitric oxide levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation: decreased nitric oxide is associated with premature ejaculation.
    Otunctemur A; Ozbek E; Kirecci SL; Ozcan L; Dursun M; Cekmen M; Ozdogan HK
    Andrologia; 2014; 46(9):951-5. PubMed ID: 24118023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation.
    Hosseini MM; Yarmohammadi H
    Urol Int; 2007; 79(1):28-32. PubMed ID: 17627164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.